Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-22-003175

EVP, Research & CSO sold 1,375 shares at $35.10 ($48,263)

  • EVP, Research & CSO acquired 1,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2022-01-11 Option exercise +1,375 $1.53 $2,104 109,075 D
Virgin Herbert EVP, Research & CSO 2022-01-11 Sale −1,375 $35.10 $48,263 107,700 D
Derivatives
Virgin Herbert EVP, Research & CSO 2022-01-11 Option exercise · Stock Option (Right to Buy) −1,375 223,630 D
Open-market sales · 1,375 sh · avg $35.10 · $48,263
Loading xslF345X03/doc4.xml…